0
This Week in JAMA | July 11, 2012|

This Week in JAMA FREE

JAMA. 2012;308(2):109. doi:10.1001/jama.2012.3093.
Text Size: A A A
Published online
Figures in this Article

ADJUVANT CHEMOTHERAPY FOR PERIAMPULLARY CARCINOMA

Periampullary adenocarcinomas, which include carcinomas of the bile duct, the ampulla of Vater, and the periampullary duodenum, are typically treated by surgical resection. Five-year survival rates following surgical resection rarely exceed 50%. To assess whether adjuvant chemotherapy might improve patient survival, Neoptolemos and colleagues randomly assigned 428 patients with surgically resected periampullary carcinomas to receive adjuvant chemotherapy (either fluorouracil plus folinic acid or gemcitabine) or no chemotherapy. The authors report that compared with no chemotherapy, treatment with gemcitabine or fluorouracil was not associated with a significant survival benefit. However, in analyses that adjusted for prognostic variables (patient age, tumor type and grade, and lymph node involvement), a survival benefit of chemotherapy was demonstrated.

ACADESINE AND EARLY OUTCOMES AFTER CABG SURGERY

Some data have suggested that perioperative and postoperative infusion of acadesine—an adenosine-regulating agent with cardioprotective potential—is associated with reductions in ischemia/reperfusion injury and adverse cardiac outcomes among patients undergoing on-pump coronary artery bypass graft (CABG) surgery. In a randomized trial that enrolled 3080 intermediate- and high-risk patients undergoing nonemergent, on-pump CABG surgery, Newman and colleagues assessed the efficacy and safety of acadesine (vs placebo) administered during the perioperative period. The authors found that compared with placebo, acadesine was not associated with a reduction in a composite outcome of all-cause mortality, nonfatal stroke, or severe left ventricular dysfunction through postoperative day 28.

ADVERSE EVENTS AFTER H1N1 VACCINATION

Risks of adverse outcomes after receipt of the influenza A(H1N1) vaccine are the subject of 2 articles in this issue. In a nationwide cohort study involving 53 432 live-born Danish infants delivered between November 2009 and October 2010, Pasternak and colleagues found that infants exposed in utero to the influenza A(H1N1)pdm09 vaccine did not have a significantly increased risk of major birth defects, preterm birth, or fetal growth restriction compared with infants without influenza vaccine exposure. De Wals and colleagues assessed the risk of Guillain-Barré syndrome following a province-wide (Quebec, Canada) influenza A(H1N1) immunization campaign that resulted in vaccination of an estimated 4.4 million residents of Quebec (57% of the target population). The authors report that vaccine recipients had a small increased risk of Guillain-Barré syndrome during the 4 to 8 weeks after vaccination—an estimated 2 cases per million doses of administered vaccine. In an editorial, Steinhoff and MacDonald discuss influenza vaccine safety, particularly vaccine safety during pregnancy.

CLINICIAN'S CORNER JAMA CLINICAL CHALLENGE

A 68-year-old woman who was recently diagnosed with small cell lung cancer presents with a bulging area behind her ear. Nine years earlier she underwent resection and radiation therapy for a recurrent hemangioblastoma, with poor medical follow-up since then. What would you do next?

MEDICAL NEWS & PERSPECTIVES

The Centers for Medicare & Medicaid Services has launched an initiative to reduce inappropriate use of antipsychotic medications for nursing home residents by 15% by the end of 2012.

VIEWPOINTS

The moral duty to buy health insurance

Patient satisfaction and patient-centered care

Ending preventable child death

Eliminating partially hydrogenated oils in foods

A PIECE OF MY MIND

“The more doctor-speak becomes second nature to us, the more it can distance ourselves from our patients.” From “Learning to Talk.”

EDITORIAL

Update on JAMA policies

EDITOR'S AUDIO SUMMARY

Dr Bauchner summarizes and comments on this week's issue. Go to http://jama.jamanetwork.com/multimedia.aspx#Weekly.

READERS RESPOND

How would you manage a patient with probable nonalcoholic fatty liver disease? Read the case at www.jama.com and submit your response by August 5 for possible online posting.

AUTHOR IN THE ROOM TELECONFERENCE

Join Peter B. Bach, MD, MAPP, and George T. O’Connor, MD, Wednesday, July 18, from 2 to 3 pm eastern time to discuss the benefits and harms of computed tomographic screening for lung cancer. To register, go to http://www.ihi.org/AuthorintheRoom.

JAMA PATIENT PAGE

For your patients: Information about hospice care.

First Page Preview

View Large
First page PDF preview

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.